Understanding Two New FDA Guidances on Posting Product Information Online

FDA recently issued two draft guidances on correcting misinformation posted on social media and other websites, and on using Internet/social media platforms with character limitations (Twitter) to ensure regulatory compliance.  What do these guidances mean for your company and how can you maximize the benefits of social medial promotion while staying within FDA's guidance and recommendations?

Join AGG's Food and Drug Practice leader, Alan Minsk, and associate, Kelley Nduom, who discussed “FDA Stops Being Antisocial – Recent Social Media Guidance Breaks the Silence” in a January webinar, explain the new guidances, make recommendations and take questions from the audience.

 If you have previously registered for this event, please login below:

Registration is required to attend this event. Please register now.
First Name*
Last Name*
I consent to receive marketing communications from Arnall Golden Gregory LLP, including webinar confirmations, legal developments, upcoming events, and industry and firm news.* 
You must have Javascript and Cookies enabled to access this webcast. Click here for Help.
Please enable Cookies in your browser before registering for the webcast.
*Denotes required.